株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

不妊治療関連機器の世界市場の予測 〜2022年:生殖補助医療(ART)・人工授精・体外受精(IVF)・代理出産・不妊症手術

Infertility Treatment Market by Procedure (ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery), Product (Instruments, Media, Accessories), Patient Type (Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecasts to 2022

発行 MarketsandMarkets 商品コード 341215
出版日 ページ情報 英文 172 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.10円で換算しております。
Back to Top
不妊治療関連機器の世界市場の予測 〜2022年:生殖補助医療(ART)・人工授精・体外受精(IVF)・代理出産・不妊症手術 Infertility Treatment Market by Procedure (ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery), Product (Instruments, Media, Accessories), Patient Type (Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecasts to 2022
出版日: 2017年05月08日 ページ情報: 英文 172 Pages
概要

不妊治療の世界市場は2017年から2022年にかけて10.6%の複合年間成長率(CAGR)で拡大し、2022年には20億5000万米ドル規模に成長すると予測されています。不妊症・不妊治療への理解の高まり、官民連携による不妊治療への取り組み、治療機関の増加、不妊治療の技術的発展などが当市場を押し上げています。

当レポートでは、不妊治療の世界市場について調査し、市場の発展動向、市場成長への各種影響因子の分析、治療法・製品・患者・エンドユーザー・地域別の動向、市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 不妊治療:市場概要
  • 各地域の不妊治療市場:治療法別
  • 不妊治療関連機器の市場規模:製品別
  • 不妊治療市場:エンドユーザー別
  • 不妊治療市場の地域概要

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
    • 課題
  • 産業動向

第6章 不妊治療市場:治療法別

  • イントロダクション
  • 生殖補助医療(ART)
    • 体外受精(IVF)
    • 代理出産
  • 人工授精
  • 不妊症手術
  • その他

第7章 不妊治療市場:製品別

  • イントロダクション
  • 治療関連機器
    • 画像システム
    • 精子分析システム
    • ワークステーション
    • 卵子吸引ポンプ
    • マイクロマニュピレーターシステム
    • インキュベーター
    • ガス分析器
    • レーザーシステム
  • メディア・消耗品
  • 付属品

第8章 不妊治療市場:患者別

  • イントロダクション
  • 女性の不妊治療
  • 男性の不妊治療

第9章 不妊治療市場:エンドユーザー別

  • イントロダクション
  • 生殖医療センター
  • 病院・診療所
  • 研究機関
  • 精子バンク

第10章 不妊治療市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 競合環境

  • 概要
  • ベンダーの選択基準
  • ベンダー概要
  • 製品
  • 事業戦略

第12章 企業プロファイル

  • THE COOPER COMPANIES INC.
  • COOK GROUP INCORPORATED
  • THERMO FISHER SCIENTIFIC, INC.
  • VITROLIFE AB
  • ESCO MICRO PTE. LTD.
  • GENEA LIMITED
  • IRVINE SCIENTIFIC
  • IVFTECH APS
  • THE BAKER COMPANY, INC.
  • 北里コーポレーション
  • RINOVUM WOMEN'S HEALTH, LLC.
  • ROCKET MEDICAL PLC
  • IHMEDICAL A/S

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3765

The global infertility treatment market is expected to reach USD 2.05 billion by 2022 from USD 1.24 billion in 2017, at a CAGR of 10.6% from 2017 to 2022. Growth in this market is primarily driven by factors such as the continuous decline in fertility rates; increasing public-private investments, funds, and grants; growing public awareness about infertility and the available treatment options; the rising number of fertility clinics worldwide; and technological advancements in infertility treatment devices are the majors drivers for the growth of the infertility treatment market. On the other hand, the high procedural cost of assisted reproductive techniques in developed markets and unsupportive government regulations for certain infertility treatment options are expected to limit market growth to a certain extent.

Based on procedure, the infertility treatment market is segmented into assisted reproductive technology (ART), artificial insemination (AI), fertility surgeries, and other procedures. In 2016, the ART segment accounted for the largest share of the infertility treatment market, by procedure, owing to increasing infertility and rising prevalence of lifestyle disorders (leading to decline in the fertility rate), technological innovations in the field of IVF, growing adoption of procedures like surrogacy by same-sex couples, and the high success rate of ART procedures.

On the basis of product, the infertility treatment market is segmented into instruments, media & consumables, and accessories. The instruments segment accounted for the largest share of the infertility treatment market in 2016, whereas the media & consumables segment is expected to grow at the fastest CAGR during the forecast period.

On the basis of end user, the market is segmented into fertility centers, hospitals & clinics, research institutes, and cryobanks. The fertility centers segment accounted for the largest share of the infertility treatment market in 2016. The increasing number of fertility centers across the globe, the high success rates in fertility centers, and increasing medical tourism are the key factors driving market growth in this segment.

The infertility treatment market is fairly competitive, with a large number of global and local manufacturers of infertility treatment products. The Cooper Companies Inc. (U.S.), Cook Group Incorporated (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) were the top three players in the infertility treatment market in 2016. Product launches, approvals, and product enhancements; agreements, partnerships, and collaborations; and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the infertility treatment market during 2014-2017.

Research Coverage:

This report studies infertility treatment market based on procedure, product, patient type, and end user. The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes the micromarkets with respect to their individual growth trends, in the infertility treatment market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the infertility treatment market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned strategies (market penetration, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product offerings and business strategies adopted by the major players in the infertility treatment market. The report analyzes the market based on procedure, product, patient type, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the infertility treatment market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various infertility treatment devices across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the infertility treatment market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the infertility treatment market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS AND LIMITATIONS
    • 2.4.1. ASSUMPTIONS
    • 2.4.2. LIMITATIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. INFERTILITY TREATMENT: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: INFERTILITY TREATMENT MARKET, BY PROCEDURE (2016)
  • 4.3. INFERTILITY TREATMENT INSTRUMENTS MARKET SIZE, BY PRODUCT, 2017 VS. 2022(USD MILLION)
  • 4.4. INFERTILITY TREATMENT MARKET, BY END USER (2017 VS. 2022)
  • 4.5. GEOGRAPHIC SNAPSHOT OF THE INFERTILITY TREATMENT MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Continuous decline in fertility rates
      • 5.2.1.2. Increasing public-private investments, funds, and grants
      • 5.2.1.3. Growing public awareness about infertility and the available treatment options
      • 5.2.1.4. Rising number of fertility clinics worldwide
      • 5.2.1.5. Technological advancements in infertility treatment devices
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High procedural cost of assisted reproductive techniques in developed markets
      • 5.2.2.2. Unsupportive government regulations for certain infertility treatment options
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growth opportunities in emerging markets
        • 5.2.3.1.1. Improving healthcare infrastructure
        • 5.2.3.1.2. Increasing medical tourism due to low treatment costs
      • 5.2.3.2. Use of fertility treatment options by single parents and same-sex couples
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Concerns related to art procedures
      • 5.2.4.2. Reduced efficacy among older women
  • 5.3. INDUSTRY TRENDS
    • 5.3.1. INCREASE IN THE USE OF TIME-LAPSE TECHNOLOGY

6. INFERTILITY TREATMENT MARKET, BY PROCEDURE

  • 6.1. INTRODUCTION
    • 6.1.1. ASSISTED REPRODUCTIVE TECHNOLOGY
      • 6.1.1.1. In vitro fertilization
        • 6.1.1.1.1. Intracytoplasmic sperm injection
        • 6.1.1.1.2. Gamete donation
      • 6.1.1.2. Surrogacy
    • 6.1.2. ARTIFICIAL INSEMINATION
      • 6.1.2.1. Intrauterine insemination
      • 6.1.2.2. Intracervical insemination
      • 6.1.2.3. Intratubal insemination
    • 6.1.3. FERTILITY SURGERIES
    • 6.1.4. OTHER PROCEDURES

7. INFERTILITY TREATMENT MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. INSTRUMENTS
    • 7.2.1. IMAGING SYSTEMS
    • 7.2.2. SPERM ANALYZER SYSTEMS
    • 7.2.3. WORKSTATIONS
    • 7.2.4. OVUM ASPIRATION PUMPS
    • 7.2.5. MICROMANIPULATOR SYSTEMS
    • 7.2.6. INCUBATORS
    • 7.2.7. GAS ANALYZERS
    • 7.2.8. LASER SYSTEMS
  • 7.3. MEDIA & CONSUMABLES
  • 7.4. ACCESSORIES

8. INFERTILITY TREATMENT MARKET, BY PATIENT TYPE

  • 8.1. INTRODUCTION
  • 8.2. FEMALE INFERTILITY TREATMENT
  • 8.3. MALE INFERTILITY TREATMENT

9. INFERTILITY TREATMENT MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. FERTILITY CENTERS
  • 9.3. HOSPITALS AND CLINICS
  • 9.4. RESEARCH INSTITUTES
  • 9.5. CRYOBANKS

10. INFERTILITY TREATMENT MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. U.K.
    • 10.3.3. FRANCE
    • 10.3.4. REST OF EUROPE
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA-PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. VENDOR INCLUSION CRITERIA
  • 11.3. VENDOR DIVE
    • 11.3.1. VANGUARDS
    • 11.3.2. INNOVATORS
    • 11.3.3. DYNAMIC
    • 11.3.4. EMERGING
  • 11.4. PRODUCT OFFERINGS
  • 11.5. BUSINESS STRATEGY

Top 25 companies analysed for this study are - The Cooper Companies Inc. (U.S.), Cook Group Incorporated (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Vitrolife AB (Sweden), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (U.S.), The Baker Company, Inc. (U.S.), Kitazato (Japan), Rinovum Women's Health Company (U.S.), Rocket Medical Plc (U.K.), IHMedical A/S (Denmark), Labotect GmbH (Germany), Hamilton Throne Ltd. (U.S.), Microtech IVF s.r.o. (Czech Republic), Zander Scientific Inc.(U.S.), Nikon Instruments Inc. (U.S.), MedGyn Products, Inc. (U.S.), Biogenics, Inc. (U.S.), INVO Bioscience (U.S.), SoMATEX Medical Technologies GmbH (Germany), LifeGlobal Group LLC (U.S.), RI.MOS (Italy), and Surelife Pte ltd. (Singapore).

12. COMPANY PROFILES: INFERTILITY TREATMENT MARKET (Overview, Products and Services, Financials, Strategy & Development)*

  • 12.1. THE COOPER COMPANIES INC.
  • 12.2. COOK GROUP INCORPORATED
  • 12.3. THERMO FISHER SCIENTIFIC, INC.
  • 12.4. VITROLIFE AB
  • 12.5. ESCO MICRO PTE. LTD.
  • 12.6. GENEA LIMITED
  • 12.7. IRVINE SCIENTIFIC
  • 12.8. IVFTECH APS
  • 12.9. THE BAKER COMPANY, INC.
  • 12.10. KITAZATO
  • 12.11. RINOVUM WOMEN'S HEALTH, LLC.
  • 12.12. ROCKET MEDICAL PLC
  • 12.13. IHMEDICAL A/S

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL INFERTILITY TREATMENT MARKET SNAPSHOT (2017 VS. 2022)
  • TABLE 2: GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 3: INFERTILITY TREATMENT MARKET SIZE FOR ASSISTED REPRODUCTIVE TECHNOLOGY, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 4: INFERTILITY TREATMENT MARKET SIZE FOR ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: IN VITRO FERTILIZATION MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: SURROGACY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: INFERTILITY TREATMENT MARKET SIZE FOR ARTIFICIAL INSEMINATION, 2015-2022 (USD MILLION)
  • TABLE 8: INFERTILITY TREATMENT MARKET SIZE FOR FERTILITY SURGERIES, 2015-2022 (USD MILLION)
  • TABLE 9: INFERTILITY TREATMENT MARKET SIZE FOR OTHER PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 10: GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 11: GLOBAL INSTRUMENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 12: GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: GLOBAL SPERM ANALYZER SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: GLOBAL WORKSTATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: GLOBAL OVUM ASPIRATION PUMPS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: GLOBAL MICROMANIPULATOR SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: GLOBAL INCUBATORS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: GLOBAL GAS ANALYZERS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: GLOBAL LASER SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: GLOBAL MEDIA & CONSUMABLES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: GLOBAL INFERTILITY TREATMENT ACCESSORIES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2015-2022 (USD MILLION)
  • TABLE 24: GLOBAL FEMALE INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: GLOBAL MALE INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 27: GLOBAL INFERTILITY TREATMENT MARKET SIZE FOR FERTILITY CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: GLOBAL INFERTILITY TREATMENT MARKET SIZE FOR HOSPITALS AND CLINICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: GLOBAL INFERTILITY TREATMENT MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: GLOBAL INFERTILITY TREATMENT MARKET SIZE FOR CRYOBANKS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 34: NORTH AMERICA: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2015-2022 (USD MILLION)
  • TABLE 36: NORTH AMERICA: INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 37: U.S.: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 38: U.S.: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 39: CANADA: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 40: CANADA: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 41: EUROPE: INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: EUROPE: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 43: EUROPE: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 44: EUROPE: INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: EUROPE: INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 46: GERMANY: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 47: GERMANY: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 48: U.K.: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 49: U.K.: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 50: FRANCE: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 51: FRANCE: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 52: REST OF EUROPE: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 53: REST OF EUROPE: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: ASIA-PACIFIC: INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 55: ASIA-PACIFIC: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 56: ASIA-PACIFIC: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 57: ASIA-PACIFIC: INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 59: JAPAN: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 60: JAPAN: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 61: CHINA: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 62: CHINA: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 63: INDIA: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 64: INDIA: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 65: REST OF ASIA-PACIFIC: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 66: REST OF ASIA-PACIFIC: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 67: ROW: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2015-2022 (USD MILLION)
  • TABLE 68: ROW: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 69: ROW: INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: ROW: INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL INFERTILITY TREATMENT MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: INFERTILITY TREATMENT MARKET: DATA TRIANGULATION
  • FIGURE 5: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 6: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 7: INFERTILITY TREATMENT MARKET SHARE, BY PRODUCT, 2017 VS. 2022
  • FIGURE 8: INFERTILITY TREATMENT MARKET SHARE, BY PATIENT TYPE, 2017 VS. 2022
  • FIGURE 9: INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: GEOGRAPHIC SNAPSHOT OF THE INFERTILITY TREATMENT MARKET
  • FIGURE 11: CONTINUOUS DECLINE IN FERTILITY RATES-PRIMARY FACTOR DRIVING THE GROWTH OF THE INFERTILITY TREATMENT MARKET
  • FIGURE 12: ASSISTED REPRODUCTIVE TECHNOLOGY DOMINATED THE GLOBAL INFERTILITY TREATMENT MARKET IN 2016
  • FIGURE 13: IMAGING SYSTEMS WILL CONTINUE TO DOMINATE THE INFERTILITY TREATMENT INSTRUMENTS MARKET IN 2022
  • FIGURE 14: FERTILITY CENTERS TO DOMINATE THE INFERTILITY TREATMENT MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 16: INFERTILITY TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: DECLINE IN THE GLOBAL FERTILITY RATE (2004-2014)
  • FIGURE 18: INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 19: INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
  • FIGURE 20: INSTRUMENTS MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
  • FIGURE 21: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 22: INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 23: NORTH AMERICA: INFERTILITY TREATMENT MARKET SNAPSHOT (2017-2022)
  • FIGURE 24: EUROPE: INFERTILITY TREATMENT MARKET SNAPSHOT (2017-2022)
  • FIGURE 25: ASIA-PACIFIC: INFERTILITY TREATMENT MARKET SNAPSHOT (2017-2022)
  • FIGURE 26: REST OF THE WORLD: INFERTILITY TREATMENT MARKET SNAPSHOT (2017-2022)
  • FIGURE 27: VENDOR DIVE: EVALUATION OVERVIEW
  • FIGURE 28: THE COOPER COMPANIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 29: THE COOPER COMPANIES, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 30: THE COOPER COMPANIES, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 31: COOK GROUP INCORPORATED: PRODUCT OFFERING SCORECARD
  • FIGURE 32: COOK GROUP INCORPORATED: BUSINESS STRATEGY SCORECARD
  • FIGURE 33: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 34: THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 35: THERMO FISHER SCIENTIFIC INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 36: VITROLIFE AB: COMPANY SNAPSHOT(2016)
  • FIGURE 37: VITROLIFE AB: PRODUCT OFFERING SCORECARD
  • FIGURE 38: VITROLIFE AB: BUSINESS STRATEGY SCORECARD
  • FIGURE 39: ESCO MICRO PTE. LTD.: PRODUCT OFFERING SCORECARD
  • FIGURE 40: ESCO MICRO PTE. LTD.: BUSINESS STRATEGY SCORECARD
  • FIGURE 41: GENEA LIMITED: PRODUCT OFFERING SCORECARD
  • FIGURE 42: GENEA LIMITED: BUSINESS STRATEGY SCORECARD
  • FIGURE 43: IRVINE SCIENTIFIC: PRODUCT OFFERING SCORECARD
  • FIGURE 44: IRVINE SCIENTIFIC: BUSINESS STRATEGY SCORECARD
  • FIGURE 45: IVFTECH APS: PRODUCT OFFERING SCORECARD
  • FIGURE 46: IVFTECH APS: BUSINESS STRATEGY SCORECARD
  • FIGURE 47: THE BAKER COMPANY, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 48: THE BAKER COMPANY, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 49: KITAZATO: PRODUCT OFFERING SCORECARD
  • FIGURE 50: KITAZATO: BUSINESS STRATEGY SCORECARD
  • FIGURE 51: RINOVUM WOMEN'S HEALTH, LLC: PRODUCT OFFERING SCORECARD
  • FIGURE 52: RINOVUM WOMEN'S HEALTH, LLC: BUSINESS STRATEGY OFFERING SCORECARD
  • FIGURE 53: ROCKET MEDICAL PLC: PRODUCT OFFERING SCORECARD
  • FIGURE 54: ROCKET MEDICAL PLC: BUSINESS STRATEGY SCORECARD
  • FIGURE 55: IHMEDICAL A/S: PRODUCT OFFERING SCORECARD
  • FIGURE 56: IHMEDICAL A/S: BUSINESS STRATEGY SCORECARD
Back to Top